evaluate the effectiveness of Emotion-Focused therapy in PMDD

Not Applicable

• Conditions: Premenstrual Dysphoric Disorder.; Other specified mood [affective] disorders; F38.8

• Registration Number: IRCT20220920055998N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 48

Inclusion Criteria

Diagnosis of PMDD disorder based on SCID-5
Regular menstrual cycle (25 to 32 days)
Minimum education is diploma

Exclusion Criteria

Pregnancy (within the last 6 months)
Breastfeeding (during the last 6 months)
Menopause
Having certain medical diseases (cardiac, respiratory, neurological diseases, high blood pressure, migraine, hormonal problems) according to the subject's self-report.
Having any psychiatric disorder for which a person takes medicine
Use of hormonal contraceptive methods
Drug abuse

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of symptoms in Premenstrual Dysphoric Disorder. Timepoint: Before the intervention, the last session, 3 months after the intervention. Method of measurement: Premenstrual Symptoms Screening Tool-PSST.

Secondary Outcome Measures

Name	Time	Method
Difficulties in Emotion Regulation. Timepoint: Before the intervention, the last session, 3 months after the intervention. Method of measurement: Difficulties in Emotion Regulation Scale (DERS).;Severity of symptoms of anxiety, depression, stress. Timepoint: Before the intervention, the last session, 3 months after the intervention. Method of measurement: Depression, Anxiety, Stress Scale-21 (DASS-21).